3,262,845Basic earnings per share$0.06$0.06$0.12$0.11Diluted earnings per share$0.06$0.06$0.12$0.11Weighted average number of commonshares outstandingBasic29,332,79129,396,27629,332,79129,396,276Diluted29,332,79129,396,27629,332,79129,396,276 Tianyin Pharmaceutical Co., Inc.Consolidated Statements of Comprehensive Income(Unaudited)For the Three Months EndedFor the Six Months EndedDecember 31,December 31,2012201120122011Net income$1,848,030$1,681,570$3,368,983$3,188,787Other comprehensive incomeForeign currency translation adjustment226,799567,535114,2991,515,042Comprehensive income2,074,8292,249,1053,483,2824,703,829Less: comprehensive income (loss)attributable to
interest(15,225)(52,025)(36,249)185,379Comprehensive income attributable toTianyin Pharmaceutical Co., Inc.$2,090,054$2,301,130$3,519,531$4,518,450 Tianyin Pharmaceutical Co., Inc.Consolidated Statements of Cash Flows(Unaudited)For the Six Months EndedDecember 31,20122011Cash flows from operating activities:Net Income$
3,188,787Adjustments to reconcile net income to net cashprovided by (used in) operating activities:Depreciation and amortization1,171,649518,131Gain on disposal of fixed assets-(229,110)Share-based payments17,730-Provision for bad debts-4
|SOURCE Tianyin Pharmaceutical Co., Inc.|
Copyright©2012 PR Newswire.
All rights reserved